Page last updated: 2024-09-05

lenalidomide and Brain Edema

lenalidomide has been researched along with Brain Edema in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Madabhavi, IV; Modi, MG; Revannasiddaiah, S; Sarkar, MS	1
Fabiano, AJ; Fenstermaker, RA; Qiu, J; Rigual, D	1

Other Studies

2 other study(ies) available for lenalidomide and Brain Edema

Article	Year
Sanctuary site central nervous system relapse-refractory DLBCL responding to nivolumab and lenalidomide. Oral oncology, 2019, Volume: 93 Topics: Adult; Brain Edema; Central Nervous System Neoplasms; Drug Administration Schedule; Humans; Injections, Spinal; Intensive Care Units; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Male; Nivolumab; Treatment Outcome	2019
Tumoral Bing-Neel Syndrome presenting as a cerebellar mass. Clinical neurology and neurosurgery, 2013, Volume: 115, Issue:6 Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Examination; Brain Edema; Cerebellar Neoplasms; Cyclophosphamide; Dexamethasone; Doxorubicin; Fatal Outcome; Humans; Lenalidomide; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Nervous System Diseases; Neurosurgical Procedures; Prednisone; Rituximab; Thalidomide; Treatment Outcome; Vidarabine; Vincristine; Waldenstrom Macroglobulinemia	2013

Article

Year

Sanctuary site central nervous system relapse-refractory DLBCL responding to nivolumab and lenalidomide.

Oral oncology, 2019, Volume: 93

Topics: Adult; Brain Edema; Central Nervous System Neoplasms; Drug Administration Schedule; Humans; Injections, Spinal; Intensive Care Units; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Male; Nivolumab; Treatment Outcome

2019

Tumoral Bing-Neel Syndrome presenting as a cerebellar mass.

Clinical neurology and neurosurgery, 2013, Volume: 115, Issue:6

Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Examination; Brain Edema; Cerebellar Neoplasms; Cyclophosphamide; Dexamethasone; Doxorubicin; Fatal Outcome; Humans; Lenalidomide; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Nervous System Diseases; Neurosurgical Procedures; Prednisone; Rituximab; Thalidomide; Treatment Outcome; Vidarabine; Vincristine; Waldenstrom Macroglobulinemia

2013